1
|
Messineo A and Marsella LT: Biological
hazards and healthcare-associated infections in Italian healthcare
facilities: Some considerations on inspections and accountability.
Ann Ig. 27:799–807. 2015.PubMed/NCBI
|
2
|
Corrao CR, Mazzotta A, La Torre G and De
Giusti M: Biological risk and occupational health. Ind Health.
50:326–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Srikanth P, Sudharsanam S and Steinberg R:
Bio-aerosols in indoor environment: Composition, health effects and
analysis. Indian J Med Microbiol. 26:302–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Heimbuch BK, Wallace WH, Balzli CL, Laning
ML, Harnish DA and Wander JD: Bioaerosol exposure to personnel in a
clinical environment absent patients. J Occup Environ Hyg.
13:D11–D15. 2016. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tarantola A, Abiteboul D and Rachline A:
Infection risks following accidental exposure to blood or body
fluids in health care workers: A review of pathogens transmitted in
published cases. Am J Infect Control. 34:367–375. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Castella A, Vallino A, Argentero PA and
Zotti CM: Preventability of percutaneous injuries in healthcare
workers: A year-long survey in Italy. J Hosp Infect. 55:290–294.
2003. View Article : Google Scholar : PubMed/NCBI
|
7
|
Pierce GE: Pseudomonas aeruginosa,
Candida albicans, and device-related nosocomial infections:
Implications, trends, and potential approaches for control. J Ind
Microbiol Biotechnol. 32:309–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Beggs CB, Kerr KG, Noakes CJ, Hathway EA
and Sleigh PA: The ventilation of multiple-bed hospital wards:
Review and analysis. Am J Infect Control. 36:250–259. 2008.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Furneri PM, Garozzo A, Musumarra MP,
Scuderi AC, Russo A and Bonfiglio G: Effects on adhesiveness and
hydrophobicity of sub-inhibitory concentrations of netilmicin. Int
J Antimicrob Agents. 22:164–167. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Shinozaki-Ushiku A, Kunita A and Fukayama
M: Update on Epstein-Barr virus and gastric cancer (Review). Int J
Oncol. 46:1421–1434. 2015.PubMed/NCBI
|
11
|
Libra M, Gloghini A, De Re V, Rupolo M,
Navolanic PM, Gasparotto D, Stivala F, Spina M, Boiocchi M and
Carbone A: Aggressive forms of non-Hodgkins lymphoma in two
patients bearing coinfection of Epstein-Barr and hepatitis C
viruses. Int J Oncol. 26:945–950. 2005.PubMed/NCBI
|
12
|
Gloghini A, Gaidano G, Larocca LM,
Pierconti F, Cingolani A, Dal Maso L, Capello D, Franceschi S,
Tirelli U, Libra M, et al: Expression of cyclin-dependent kinase
inhibitor p27Kip1 in AIDS-related diffuse large-cell
lymphomas is associated with Epstein-Barr virus-encoded latent
membrane protein 1. Am J Pathol. 161:163–171. 2002. View Article : Google Scholar : PubMed/NCBI
|
13
|
Arzumanyan A, Reis HM and Feitelson MA:
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular
carcinoma. Nat Rev Cancer. 13:123–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
De Re V, Caggiari L, De Zorzi M, Repetto
O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A,
Sansonno D, et al: Genetic diversity of the KIR/HLA system and
susceptibility to hepatitis C virus-related diseases. PLoS One.
10:e01174202015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Beral V, Peterman T, Berkelman R and Jaffe
H: AIDS-associated non-Hodgkin lymphoma. Lancet. 337:805–809. 1991.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Libra M, Scalisi A, Vella N, Clementi S,
Sorio R, Stivala F, Spandidos DA and Mazzarino C: Uterine cervical
carcinoma: Role of matrix metalloproteinases (Review). Int J Oncol.
34:897–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Petry KU: HPV and cervical cancer. Scand J
Clin Lab Invest Suppl. 244:59–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ewers EC, Shah PA, Carmichael MG and
Ferguson TM: Concurrent systemic chemoimmunotherapy and
sofosbuvir-based antiviral treatment in a hepatitis C
virus-infected patient with diffuse large B-cell lymphoma. Open
Forum Infect Dis. 3:ofw2232016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Giofrè SV, Romeo R, Carnovale C, Mancuso
R, Cirmi S, Navarra M, Garozzo A and Chiacchio MA: Synthesis and
biological properties of
5-(1H-1,2,3-triazol-4-yl)isoxazolidines: A new class of
C-nucleosides. Molecules. 20:5260–5275. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Marconi A, Candido S, Talamini R, Libra M,
Nicoletti F, Spandidos DA, Stivala F and Proietti L: Prevalence of
hepatitis C virus infection among health-care workers: A 10-year
survey. Mol Med Rep. 3:561–564. 2010.PubMed/NCBI
|
21
|
Rapisarda V, Marconi A, Candido S,
Nicolosi D, Salmeri M, Gangemi P, Proietti L, Spandidos DA, Bracci
M, Fenga C, et al: A tailored health surveillance program unveils a
case of MALT lymphoma in an HCV-positive health-care worker. Oncol
Lett. 5:651–654. 2013.PubMed/NCBI
|
22
|
Maniar HH, Tawari AA, Suk M, Bowen TR and
Horwitz DS: Percutaneous and mucocutaneous exposure among
orthopaedic surgeons: Immediate management and compliance with CDC
protocol. J Orthop Trauma. 29:e391–e394. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mohammadi N, Allami A and Mohamadi Malek
R: Percutaneous exposure incidents in nurses: Knowledge, practice
and exposure to hepatitis B infection: Percutaneous exposure
incidents in nurses. Hepat Mon. 11:186–190. 2011.PubMed/NCBI
|
24
|
Petrucci C, Alvaro R, Cicolini G, Cerone
MP and Lancia L: Percutaneous and mucocutaneous exposures in
nursing students: An Italian observational study. J Nurs Scholarsh.
41:337–343. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kosgeroglu N, Ayranci U, Vardareli E and
Dincer S: Occupational exposure to hepatitis infection among
Turkish nurses: Frequency of needle exposure, sharps injuries and
vaccination. Epidemiol Infect. 132:27–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Alese OO, Alese MO, Ohunakin A and Oluyide
PO: Seroprevalence of hepatitis B surface antigen and occupational
risk factors among health care workers in Ekiti State, Nigeria. J
Clin Diagn Res. 10:LC16–LC18. 2016.PubMed/NCBI
|
27
|
Chiarakul S, Eunumjitkul K, Vuttiopas S,
Vorapimol AR, Kaewkungwal J and Poovorawan Y: Seroprevalence and
risk factors of hepatitis B virus infection among health care
workers at the Institute of Neurology. J Med Assoc Thai.
90:1536–1545. 2007.PubMed/NCBI
|
28
|
Ciorlia LA and Zanetta DM: Hepatitis B in
healthcare workers: Prevalence, vaccination and relation to
occupational factors. Braz J Infect Dis. 9:384–389. 2005.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Mischke C, Verbeek JH, Saarto A, Lavoie
MC, Pahwa M and Ijaz S: Gloves, extra gloves or special types of
gloves for preventing percutaneous exposure injuries in healthcare
personnel. Cochrane Database Syst Rev. 3:CD0095732014.
|
30
|
Mbaisi EM, Nganga Z, Wanzala P and Omolo
J: Prevalence and factors associated with percutaneous injuries and
splash exposures among health-care workers in a provincial
hospital, Kenya, 2010. Pan Afr Med J. 14:102013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Prüss-Ustün A, Rapiti E and Hutin Y:
Estimation of the global burden of disease attributable to
contaminated sharps injuries among health-care workers. Am J Ind
Med. 48:482–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
32
|
Westermann C, Peters C, Lisiak B, Lamberti
M and Nienhaus A: The prevalence of hepatitis C among healthcare
workers: A systematic review and meta-analysis. Occup Environ Med.
72:880–888. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Prüss-Ustün A, Rapiti E and Hutin Y: Sharp
injuries: Global burden of disease from sharp injuries to
health-care workersEnvironmental Burden of Disease Series. No. 3.
Prüss-Üstün A, Campbell-Lendrum D, Corvalán C and Woodward A: World
Health Organisation; Geneva: 2003
|
34
|
Proietti L, Malaponte G, Libra M,
Navolanic PM, Bevelacqua Y, Travali S and Mazzarino MC: Analysis of
hepatitis C virus infection among health-care workers: An
observational study. Minerva Gastroenterol Dietol. 51:255–259.
2005.PubMed/NCBI
|
35
|
Haiduven DJ, Phillips ES, Clemons KV and
Stevens DA: Percutaneous injury analysis: Consistent
categorization, effective reduction methods, and future strategies.
Infect Control Hosp Epidemiol. 16:582–589. 1995. View Article : Google Scholar : PubMed/NCBI
|
36
|
Tarigan LH, Cifuentes M, Quinn M and
Kriebel D: Prevention of needle-stick injuries in healthcare
facilities: A meta-analysis. Infect Control Hosp Epidemiol.
36:823–829. 2015. View Article : Google Scholar : PubMed/NCBI
|
37
|
De Carli G, Abiteboul D and Puro V: The
importance of implementing safe sharps practices in the laboratory
setting in Europe. Biochem Med (Zagreb). 24:45–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Davanzo E, Frasson C, Morandin M and
Trevisan A: Occupational blood and body fluid exposure of
university health care workers. Am J Infect Control. 36:753–756.
2008. View Article : Google Scholar : PubMed/NCBI
|
39
|
van Gemert-Pijnen J, Hendrix MG, Van der
Palen J and Schellens PJ: Effectiveness of protocols for preventing
occupational exposure to blood and body fluids in Dutch hospitals.
J Hosp Infect. 62:166–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
40
|
Denniston MM, Jiles RB, Drobeniuc J,
Klevens RM, Ward JW, McQuillan GM and Holmberg SD: Chronic
hepatitis C virus infection in the United States, National Health
and Nutrition Examination Survey 2003 to 2010. Ann Intern Med.
160:293–300. 2014. View
Article : Google Scholar : PubMed/NCBI
|
41
|
Bartosch B, Thimme R, Blum HE and Zoulim
F: Hepatitis C virus-induced hepatocarcinogenesis. J Hepatol.
51:810–820. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Taborelli M, Polesel J, Montella M, Libra
M, Tedeschi R, Battiston M, Spina M, Di Raimondo F, Pinto A, Crispo
A, et al: Hepatitis B and C viruses and risk of non-Hodgkin
lymphoma: A case-control study in Italy. Infect Agent Cancer.
11:272016. View Article : Google Scholar : PubMed/NCBI
|
43
|
Cacoub P, Commarmond C, Sadoun D and
Desbois AC: Hepatitis C virus infection and rheumatic diseases: The
impact of direct-acting antiviral agents. Rheum Dis Clin North Am.
43:123–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
44
|
Cacoub P, Comarmond C, Domont F, Savey L,
Desbois AC and Saadoun D: Extrahepatic manifestations of chronic
hepatitis C virus infection. Ther Adv Infect Dis. 3:3–14. 2016.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Terrier B and Cacoub P: Renal involvement
in HCV-related vasculitis. Clin Res Hepatol Gastroenterol.
37:334–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
46
|
Aslam F, Alam M and Lakkis NM: Hepatitis C
and carotid atherosclerosis: A retrospective analysis.
Atherosclerosis. 209:340–343. 2010. View Article : Google Scholar : PubMed/NCBI
|
47
|
Libra M, Polesel J, Russo AE, De Re V,
Cinà D, Serraino D, Nicoletti F, Spandidos DA, Stivala F and
Talamini R: Extrahepatic disorders of HCV infection: A distinct
entity of B-cell neoplasia? Int J Oncol. 36:1331–1340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Libra M, Gloghini A, Malaponte G, Gangemi
P, De Re V, Cacopardo B, Spandidos DA, Nicoletti F, Stivala F,
Zignego AL, et al: Association of t(14;18) translocation with HCV
infection in gastrointestinal MALT lymphomas. J Hepatol.
49:170–174. 2008. View Article : Google Scholar : PubMed/NCBI
|
49
|
Libra M, Gasparotto D, Gloghini A,
Navolanic PM, De Re V and Carbone A: Hepatitis C virus (HCV) I
hepatitis C virus (HCV) infection and lymphoproliferative
disorders. Front Biosci. 10:2460–2471. 2005. View Article : Google Scholar : PubMed/NCBI
|
50
|
Beggs C, Knibbs LD, Johnson GR and
Morawska L: Environmental contamination and hospital-acquired
infection: Factors that are easily overlooked. Indoor Air.
25:462–474. 2015. View Article : Google Scholar : PubMed/NCBI
|